Afficher la notice abrégée

dc.contributor.authorSánchez Molina, Ana Isabel
dc.contributor.authorBenrimoj, Shalom Isaac
dc.contributor.authorFerri García, Ramón 
dc.contributor.authorMartínez Martínez, Fernando 
dc.contributor.authorGastelurrutia, Miguel Ángel
dc.contributor.authorAmador-Fernández, Noelia
dc.contributor.authorGarcía Cárdenas, Victoria
dc.date.accessioned2025-02-12T10:57:44Z
dc.date.available2025-02-12T10:57:44Z
dc.date.issued2025-03
dc.identifier.citationA.I. Sanchez-Molina et al. Exploratory Research in Clinical and Social Pharmacy 17 (2025) 100555. https://doi.org/10.1016/j.rcsop.2024.100555es_ES
dc.identifier.urihttps://hdl.handle.net/10481/102228
dc.descriptionThis work was supported by the Spanish General Council of Official Colleges of Pharmacists through a grant from Cinfa Pharmaceuticals. The Spanish General Council of Official Colleges of Pharmacy assisted with the selection of the study locations and contacting community pharmacies (contract number 21/1/204 UGR.CGCOF).es_ES
dc.description.abstractBackground Collaborative practice between physicians and pharmacists is particularly important in the provision of pharmacy services, such as Comprehensive Medication Reviews (CMR), which often require a close coordination between these professionals. Understanding the level and nature of this collaboration can assist in the development of strategies to enhance integrated care. Objectives (1) To evaluate the changes in level of collaborative practice between community pharmacists and physicians in the context of a CMR service compared to usual practice, from the perspective of community pharmacists, and (2) to explore the determinants of such collaborative practice. Design This research was conducted alongside a 12-months prospective longitudinal observational study. Methods Community pharmacists providing CMR and pharmacists providing usual care (nCMR) from six provinces in Spain participated in the study. To measure the level of collaborative practice from the perspective of the community pharmacist, a previously validated tool was used. Collaborative practice was assessed at baseline, 6 months and 12 months. A multiple regression analysis was undertaken. Results 323 pharmacists participated in the study. At the 12-month time point there were statistical differences between CMR and nCMR groups for all factors considered in the level of collaborative practice. Determinants which showed positive significant differences between groups included: rural location of the pharmacy, pharmacists being a pharmacy owner, and female gender of the physician. The age of the pharmacist was negatively associated with higher levels of collaborative practice. Conclusion The study provides novel evidence on the level and nature of the collaborative practice between community pharmacists and physicians.es_ES
dc.description.sponsorshipSpanish General Council of Official Colleges of Pharmacy 21/1/204 UGR.CGCOFes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectPrimary health care es_ES
dc.subjectPharmacistses_ES
dc.subjectPhysicianses_ES
dc.subjectCooperative behavioures_ES
dc.subjectMedication reviewes_ES
dc.titleBridging the gap: Enhancing pharmacist-physiscian collaboration through the provision of comprehensive medication reviews in community pharmacyes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.rcsop.2024.100555
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional